As the FTC continues to crack down on pharmaceutical manufacturers’ allegedly improper listing of patents in the FDA Orange ...

The Federal Trade Commission (FTC) under Chair Lina Khan took an aggressive approach to tackling anticompetitive behavior in ...

Q3 2024 Earnings Call Transcript November 14, 2024 Operator: Hello, everyone, and thank you for holding, and welcome to the ...

Iterum Therapeutics ( (ITRM) ) has released its Q3 earnings. Here is a breakdown of the information Iterum Therapeutics presented to its ...

Advancing two pivotal Phase 3 trials of BXCL501 for acute treatment of agitation associated with bipolar disorders, ...

FDA's Orange Book: Iterum has submitted patent information for four U.S. patents for ORLYNVAH TM that will be listed in FDA's Orange Book: Approved Drug Products with Therapeutic Equivalence ...

Research and development (R&D) expenses for the third quarter 2024 were $3.1 million compared to $14.9 million for the same period in 2023. The decrease for the three-month period was primarily due to ...

Adapted from the 2014 biography titled ‘The Short and Tragic Life of Robert Peace’ written by Jeff Hobbs, ‘Rob Peace’ is a ...

Pope Francis was raised in the city’s middle-class Flores neighborhood from the mid-1930s through the ’50s, a time period ...

Good afternoon, ladies and gentlemen, and welcome, everyone, to the Maravai LifeSciences Third Quarter 2024 Earnings Conference Call. All lines have been placed on mute to prevent any background noise ...

Sandoz Inc.’s proposed generic version of Inlyta infringes a patent for the kidney-cancer chemotherapy treatment, Pfizer Inc.

Under Donald Trump and Joe Biden alike, the US has been determined to “reshore” chipmaking. Now money and colossal ...